Tools / Resources
Differentiated Care for Adults at High Risk of HIV Disease Progression: A Call to Action
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies...
Differentiated Care for Adults at High Risk of HIV Disease Progression: A Call to Action
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies...
December 2017: EARNEST trial looks at long-term efficacy of second-line ART regimens
Article and Study Summary Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Published in: Lancet...
